Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738. https://doi.org/10.1056/NEJMra0905750
Article CAS PubMed PubMed Central Google Scholar
Douglas RS et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382(4):341–352. https://doi.org/10.1056/NEJMoa1910434
Article CAS PubMed Google Scholar
Bartalena L, Tanda ML (2022) Current concepts regarding Graves’ orbitopathy. J Intern Med 292(5):692–716. https://doi.org/10.1111/joim.13524
Article CAS PubMed PubMed Central Google Scholar
Bartalena L et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185(4):G43–G67. https://doi.org/10.1530/EJE-21-0479
Article CAS PubMed Google Scholar
Li Y et al (2024) Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 262(1):203–210. https://doi.org/10.1007/s00417-023-06256-1
Mawn LA et al (2018) Soft tissue metrics in thyroid eye disease: an international thyroid eye disease society reliability study. Ophthalmic Plast Reconstr Surg 34(6):544–546. https://doi.org/10.1097/IOP.0000000000001080
Bartalena L et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273–285. https://doi.org/10.1530/EJE-07-0666
Article CAS PubMed Google Scholar
Tachibana S et al (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ ophthalmopathy. Endocr J 57(10):853–861. https://doi.org/10.1507/endocrj.k10e-156
Das T et al (2019) T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye (Lond) 33(2):235–243. https://doi.org/10.1038/s41433-018-0304-z
Lecler A (2021) Expanding diagnostic tools for dysthyroid optic neuropathy: how quantitative MRI can be used to visualize and measure orbital inflammation. Eur Radiol 31(10):7417–7418. https://doi.org/10.1007/s00330-021-08208-x
Zhang H et al (2023) Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front Endocrinol (Lausanne) 14:1292519. https://doi.org/10.3389/fendo.2023.1292519
Liu X et al (2021) Application of magnetic resonance imaging in the evaluation of disease activity in Graves’ ophthalmopathy. Endocr Pract 27(3):198–205. https://doi.org/10.1016/j.eprac.2020.09.008
Ge Q et al (2021) Quantitative evaluation of activity of thyroid-associated ophthalmopathy using short-tau inversion recovery (STIR) sequence. BMC Endocr Disord 21(1):226. https://doi.org/10.1186/s12902-021-00895-3
Article PubMed PubMed Central Google Scholar
Lingam RK, Mundada P, Lee V (2018) Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave’s orbitopathy: an initial observational cohort study. Orbit 37(5):325–330. https://doi.org/10.1080/01676830.2017.1423343
Higashiyama T, Iwasa M, Ohji M (2017) Quantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensity. Sci Rep 7(1):16874. https://doi.org/10.1038/s41598-017-17257-6
Article CAS PubMed PubMed Central Google Scholar
Ollitrault A et al (2021) Dixon-T2WI magnetic resonance imaging at 3 tesla outperforms conventional imaging for thyroid eye disease. Eur Radiol 31(7):5198–5205. https://doi.org/10.1007/s00330-020-07540-y
Wong NTY et al (2023) Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis. BMC Ophthalmol 23(1):347. https://doi.org/10.1186/s12886-023-03008-x
Article PubMed PubMed Central Google Scholar
Zhang H et al (2023) Application of quantitative MRI in thyroid eye disease: imaging techniques and clinical practices. J Magn Reson Imaging. https://doi.org/10.1002/jmri.29114
Article PubMed PubMed Central Google Scholar
Hu H et al (2020) Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Endocrine 70(2):372–379. https://doi.org/10.1007/s12020-020-02367-5
Article CAS PubMed Google Scholar
Cheng J et al (2023) Evaluation of activity of Graves’ orbitopathy with multiparameter orbital magnetic resonance imaging (MRI). Quant Imaging Med Surg 13(5):3040–3049. https://doi.org/10.21037/qims-22-814
Article PubMed PubMed Central Google Scholar
Zhang H et al (2024) Whole-orbit radiomics: machine learning-based multi- and fused- region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease. J Transl Med 22(1):56. https://doi.org/10.1186/s12967-023-04792-2
Article CAS PubMed PubMed Central Google Scholar
Bartalena L (2013) Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9(12):724–734. https://doi.org/10.1038/nrendo.2013.193
Article CAS PubMed Google Scholar
Song C et al (2023) Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy. Eur Radiol 33(12):9203–9212. https://doi.org/10.1007/s00330-023-09848-x
Xu L et al (2017) Thickness of extraocular muscle and orbital fat in MRI predicts response to glucocorticoid therapy in Graves’ ophthalmopathy. Int J Endocrinol 2017:3196059. https://doi.org/10.1155/2017/3196059
Article CAS PubMed PubMed Central Google Scholar
Gagliardo C et al (2020) Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur Radiol 30(4):2138–2141. https://doi.org/10.1007/s00330-019-06570-5
Wu D et al (2021) Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy. Eur J Radiol 141:109815. https://doi.org/10.1016/j.ejrad.2021.109815
Chen L et al (2021) Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Br J Radiol 94(1118):20200884. https://doi.org/10.1259/bjr.20200884
Armstrong RA (2013) Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Opt 33(1):7–14. https://doi.org/10.1111/opo.12009
Ma Z et al (2019) Improvement of the MRI and clinical features of Asian Graves’ ophthalmopathy by radiation therapy with steroids. Jpn J Radiol 37(8):612–618. https://doi.org/10.1007/s11604-019-00846-y
Das T et al (2019) T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Eye 33(2):235–243. https://doi.org/10.1038/s41433-018-0304-z
Chaobin ZYHXZZLCZ (2021) Clinical significance of Dixon quantificatioin in evaluation of thyroid⁃related ophthalmopathy. Chin J Biomed Eng. https://doi.org/10.3760/cma.j.cn115668⁃20210601⁃00112
Lee BW et al (2018) Transcriptome analysis of orbital adipose tissue in active thyroid eye disease using next generation RNA sequencing technology. Open Ophthalmol J 12:41–52. https://doi.org/10.2174/1874364101812010041
Article CAS PubMed PubMed Central Google Scholar
Garau LM et al (2018) Extraocular muscle sampled volume in Graves’ orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences. Acta Radiol Open 7(6):2058460118780892. https://doi.org/10.1177/2058460118780892
Article PubMed PubMed Central Google Scholar
Nagy EV et al (2000) Graves’ ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol 142(6):591–597. https://doi.org/10.1530/eje.0.1420591
Article CAS PubMed Google Scholar
Imbrasienė D, Jankauskienė J, Stanislovaitienė D (2010) Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves’ ophthalmopathy. Medicina (Kaunas) 46(7):472–476
留言 (0)